Home > Boards > US OTC > Biotechs > BioVie Inc. (BIVID)

New Filing for Uplisting: S-1/A

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ejobkar Member Profile
 
Followed By 0
Posts 73
Boards Moderated 0
Alias Born 03/05/12
160x600 placeholder
ejobkar   Wednesday, 10/02/19 07:48:43 AM
Re: None
Post # of 726 
New Filing for Uplisting: S-1/A

"On September 27, 2019, the last reported sale price for our common stock as reported on the OTCQB Marketplace was $8.75 per share, after giving effect to our planned 1:125 reverse stock split. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and the recent market price used throughout this prospectus may not be indicative of the final offering price. Our common stock has been approved for listing on The NASDAQ Capital Market (“Nasdaq”) under the symbol “BIVI” and we have applied for listing of the warrants on Nasdaq under the symbol “BIVIW.”

https://www.sec.gov/Archives/edgar/data/1580149/000152013819000360/bivi-20191001_s1a4.htm

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist